Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b25-00574 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Yukiro Kurokawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295, Japan. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Radiation-Protective Agents, Radiation Injuries, Experimental. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Histone deacetylases (HDACs) regulate chromatin structure and gene expression, and their inhibition has been proposed as a radioprotective strategy. However, few studies have compared multiple HDAC inhibitors (HDACis) under identical conditions. This study evaluated the efficacy of seven HDACis in a mouse total body irradiation (TBI) model. Male ICR mice received 7.5 Gy TBI followed by a single administration of valproic acid (VPA; 300 or 600 mg/kg), sodium butyrate (NaB; 500 or 1000 mg/kg), trichostatin A (TSA; 0.5 or 1.0 mg/kg), vorinostat (10 or 50 mg/kg), panobinostat (25 or 50 mg/kg), givinostat (5 or 10 mg/kg), or entinostat (25 or 50 mg/kg). Survival was monitored for 20 d. Only VPA at 600 mg/kg significantly improved survival compared with vehicle (overall p = 0.00241; p = 0.0039 vs. vehicle), while all other HDACis showed no significant benefit. VPA's efficacy may reflect a combination of effects on DNA repair, inflammation, and redox regulation rather than HDAC inhibition alone. These findings suggest VPA to be a promising candidate for radioprotection and emphasize the need for further studies to optimize dosing and explore underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295, Japan.
- Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan.
Zitieren
APA
Kurokawa, Y., Watanabe, S., Yano, T., Hidaka, N., Yamaguchi, T., & Tanaka, M. (2025). Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00574
Vancouver
Kurokawa Y, Watanabe S, Yano T, Hidaka N, Yamaguchi T, Tanaka M. Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00574
BibTeX
@article{Kurokawa2025,
author = {Kurokawa, Yukiro and Watanabe, Shinichi and Yano, Takaaki and Hidaka, Noriaki and Yamaguchi, Takumi and Tanaka, Mamoru},
title = {Comparative Study of Histone Deacetylase Inhibitors for Radiation Protection Using Survival Outcomes in a Mouse Model},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b25-00574}
}
EUVIMED